Krsnaa Diagnostics Ltd is a growing healthcare diagnostics company in India that focuses on delivering affordable diagnostic services across the country. The company operates through a mix of pathology and radiology services, largely under public-private partnership (PPP) models, making healthcare accessible in tier-2 and tier-3 cities.

With increasing healthcare awareness, rising demand for preventive testing, and government support for public healthcare infrastructure, the company is well-positioned for long-term expansion. Investors tracking the Krsnaa Diagnostics Ltd Share Price Target from 2026 to 2030 are focusing on its scalable business model and steady demand outlook.

Krsnaa Diagnostics Ltd Share Price Target 2026 to 2030 (Overview)

Latest Share Price & Market Data

About the Company

Krsnaa Diagnostics Ltd operates in the healthcare diagnostics segment, offering services such as pathology testing, radiology imaging, and tele-radiology. The company’s primary strength lies in its cost-efficient model and large-scale partnerships with government healthcare institutions.

Business Model

• PPP-based diagnostic services in government hospitals
• Revenue from pathology, radiology, and diagnostic imaging
• Focus on high-volume, low-cost testing
• Technology-enabled operations

Industry Position

• Strong presence in underserved markets
• Competes with private diagnostic chains
• Focused on affordability and accessibility

Fundamental Overview

Market Capitalization

The company has a market cap of ₹1,945 crore, placing it in the small-cap category with potential for higher growth.

Book Value

With a book value of ₹292.33 per share, the stock is trading at a moderate premium, reflecting growth expectations.

Beta

A beta of 1.02 indicates moderate volatility, meaning the stock tends to move in line with the broader market.

Financial Positioning

• Asset-light PPP model
• Stable revenue through long-term contracts
• Improving operational margins
• Strong demand visibility

Shareholding Pattern

Key Growth Drivers

1. Expansion of Government Healthcare Programs

Increased investment in public healthcare infrastructure is supporting diagnostic service providers.

2. Growing Demand for Preventive Healthcare

More people are opting for regular health checkups, increasing diagnostic volumes.

3. Geographic Expansion

The company is expanding into new regions, especially underserved areas.

4. Scalable PPP Model

The PPP model enables rapid expansion with relatively lower capital investment.

5. Technology Adoption

Digital reporting and tele-radiology services improve efficiency and scalability.

Risks to Consider

1. Dependence on Government Contracts

A significant portion of revenue comes from government partnerships.

2. Margin Pressure

Pricing under government contracts may limit profitability.

3. Competitive Landscape

Competition from established private diagnostic chains.

4. Execution Risk

Delays in project implementation can affect growth.

5. Regulatory Risks

Policy changes in healthcare may impact operations.

Year-wise Share Price Target Analysis

Krsnaa Diagnostics Ltd Share Price Target 2026

• Target Range: ₹700 – ₹850
• Growth expected from higher diagnostic volumes
• Expansion in government projects

Outlook: Stable growth supported by rising healthcare demand.

Krsnaa Diagnostics Ltd Share Price Target 2027

• Target Range: ₹850 – ₹1,000
• New contracts and operational efficiency improvements
• Increased geographic presence

Outlook: Gradual improvement in revenue and margins.

Krsnaa Diagnostics Ltd Share Price Target 2028

• Target Range: ₹1,000 – ₹1,200
• Better capacity utilization
• Stronger operational performance

Outlook: Growth phase with improving profitability.

Krsnaa Diagnostics Ltd Share Price Target 2029

• Target Range: ₹1,200 – ₹1,450
• Benefits from long-term contracts
• Enhanced market position

Outlook: Attractive for long-term investors.

Krsnaa Diagnostics Ltd Share Price Target 2030

• Target Range: ₹1,450 – ₹1,750
• Continued demand for healthcare services
• Strong business scalability

Outlook: Potential for steady long-term returns.

Long-Term Investment Outlook

Krsnaa Diagnostics Ltd offers exposure to India’s growing healthcare diagnostics sector. Its focus on affordability and partnerships with public healthcare systems gives it a unique advantage.

The stock may suit:

• Investors seeking small-cap growth opportunities
• Those with moderate risk appetite
• Long-term investors focused on healthcare

However, monitoring execution and policy risks is important.

Quick Summary

The Krsnaa Diagnostics Ltd Share Price Target from 2026 to 2030 reflects steady growth driven by rising healthcare demand, expansion in underserved markets, and a scalable business model. While risks remain, the company’s long-term outlook appears stable.

FAQ Section

What is the Krsnaa Diagnostics Ltd share price target for 2026?

The estimated target for 2026 is between ₹700 and ₹850.

What is the share price target for 2030?

The projected target for 2030 is between ₹1,450 and ₹1,750.

Is Krsnaa Diagnostics Ltd a good long-term investment?

It can be suitable for long-term investors looking for growth in the healthcare sector.

What factors affect the share price?

Key factors include government contracts, demand for diagnostics, competition, and regulatory changes.

Does the company pay dividends?

Yes, the company currently offers a small dividend yield of around 0.46%.

Disclaimer

This article is for informational purposes only and should not be considered investment advice. Please consult a financial advisor before making any investment decisions.